1. De novo MYH9 mutation in congenital scalp hemangioma
   Elena I. Fomchenko et al, 2018, Molecular Case Studies CrossRef
2. Two Motors and One Spring: Hypothetic Roles of Non-Muscle Myosin II and Submembrane Actin-Based Cytoskeleton in Cell Volume Sensing
   Nadezhda Barvitenko et al, 2021, International Journal of Molecular Sciences CrossRef
3. Expression and function of the stromal cell-derived factor-1 (SDF-1) and CXC chemokine receptor 4 (CXCR4) in the swine ovarian follicle
   G. Basini et al, 2020, Domestic Animal Endocrinology CrossRef
4. MYH9 is crucial for stem cell-like properties in non-small cell lung cancer by activating mTOR signaling
   Meng Chen et al, 2021, Cell Death Discovery CrossRef
5. HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3β via PI3K/Akt/c-Jun signaling to promote malignant progression and chemoresistance in gliomas
   Tianshi Que et al, 2021, Cell Death & Disease CrossRef
6. The 5T4 oncofetal glycoprotein does not act as a general organizer of the CXCL12 system in cancer cells
   Malte Puchert et al, 2018, Experimental Cell Research CrossRef
7. Targeted Delivery of Therapeutics to Urological Cancer Stem Cells
   Qiang Liu et al, 2020, Current Pharmaceutical Design CrossRef
8. The MYH9 Cytoskeletal Protein Is a Novel Corepressor of Androgen Receptors
   Chunhua Liu et al, 2021, Frontiers in Oncology CrossRef
9. NAP1L5 targeting combined with MYH9 Inhibit HCC progression through PI3K/AKT/mTOR signaling pathway
   Rui Zhao et al, 2022, Aging CrossRef
10. Pathological changes in GPCR signal organisation: Opportunities for targeted therapies for triple negative breast cancer
    Terrance Lam et al, 2023, Pharmacology & Therapeutics CrossRef
11. Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9
    YongHao Li et al, 2019, Signal Transduction and Targeted Therapy CrossRef
12. The CXCL12-CXCR4 signaling promotes oocyte maturation by regulating cumulus expansion in sheep
    Rui-Na Zhang et al, 2018, Theriogenology CrossRef
13. MYH9: A key protein involved in tumor progression and virus-related diseases
    Qing Liu et al, 2024, Biomedicine & Pharmacotherapy CrossRef
14. Current updates and future perspectives on the management of renal cell carcinoma
    Deepika Singh, 2021, Life Sciences CrossRef
15. Demystifying the CXCR4 conundrum in cancer biology: Beyond the surface signaling paradigm
    Mushtaq Ahmad Nengroo et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
16. MICAL2 is a novel nucleocytoplasmic shuttling protein promoting cancer invasion and growth of lung adenocarcinoma
    Wolong Zhou et al, 2020, Cancer Letters CrossRef
17. A feed-forward loop between nuclear translocation of CXCR4 and HIF-1α promotes renal cell carcinoma metastasis
    Yi Bao et al, 2019, Oncogene CrossRef
18. Clinicopathological and prognostic significance of CXCR4 high expression in renal cell carcinoma: A meta-analysis and literature review
    Xiaosan Si et al, 2019, International Journal of Surgery CrossRef
19. Myosins in the Nucleus
    Ivan V. Maly et al, 2020, Myosins CrossRef
20. Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases
    Salomé Gonçalves-Monteiro et al, 2021, Pharmaceuticals CrossRef